Risk estimation for familial breast cancer: Improving the system of counselling

Helen Gregory, Sarah Wordsworth, Barbara Gibbons, Brenda Wilson, Neva Elizabeth Haites

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Women with a family history of breast cancer dominate referrals for cancer genetic risk counselling across Europe. Given limited health care resources, managing this demand, while achieving good value for money for health services, is a major challenge. The paper reports the benefits and associated costs of moving from a traditional system of deriving family history of cancer during the patient's initial clinic attendance, to a protocol-driven system with pre-counselling assessment of family history. The evaluation was based on retrospective clinical data and a clinical audit. Changes in risk between referral and final risk assessment were ascertained and the cost difference between the two systems estimated. The study results showed that 14% of women assessed as 'low' genetic risk at referral were reassessed as 'moderate' or 'high' genetic risk for breast cancer following verification of family history. Sixteen per cent of those assessed as 'moderate' or 'high' genetic risk at referral were reassessed as 'low' genetic risk for breast cancer. Compared to the traditional system, the new protocol-driven system of risk assessment was more consistent, which reduced the number of return appointments and created time for clinicians to spend with other patients. The estimated cost of family history verification and genetic clinic appointment was calculated as 91.68 pounds (132.53 euro) per family history, compared to 104.00 pounds (150.34 euro) for the traditional system, representing a slight reduction in health service costs. Finally, the protocol-driven system can be used as part of ongoing audit for planning future genetics services in Scotland.
Original languageEnglish
Pages (from-to)1139-1144
Number of pages6
JournalEJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.
Volume15
Issue number11
Early online date18 Jul 2007
DOIs
Publication statusPublished - Nov 2007

Fingerprint

Counseling
Referral and Consultation
Breast Neoplasms
Health Services
Appointments and Schedules
Genetic Services
Clinical Audit
Costs and Cost Analysis
Health Resources
Genetic Counseling
Scotland
Health Care Costs
Cost-Benefit Analysis
Familial Breast Cancer
Neoplasms
Delivery of Health Care

Keywords

  • adult
  • aged, 80 and over
  • breast neoplasms
  • female
  • genetic counseling
  • health services needs and demand
  • humans
  • male
  • middle aged
  • retrospective studies
  • risk assessment
  • risk factors
  • breast cancer
  • cost
  • model of care

Cite this

Risk estimation for familial breast cancer : Improving the system of counselling. / Gregory, Helen; Wordsworth, Sarah; Gibbons, Barbara; Wilson, Brenda; Haites, Neva Elizabeth.

In: EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , Vol. 15, No. 11, 11.2007, p. 1139-1144.

Research output: Contribution to journalArticle

Gregory, Helen ; Wordsworth, Sarah ; Gibbons, Barbara ; Wilson, Brenda ; Haites, Neva Elizabeth. / Risk estimation for familial breast cancer : Improving the system of counselling. In: EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. . 2007 ; Vol. 15, No. 11. pp. 1139-1144.
@article{8f2a7d90e81d4d2ab6867affaf183527,
title = "Risk estimation for familial breast cancer: Improving the system of counselling",
abstract = "Women with a family history of breast cancer dominate referrals for cancer genetic risk counselling across Europe. Given limited health care resources, managing this demand, while achieving good value for money for health services, is a major challenge. The paper reports the benefits and associated costs of moving from a traditional system of deriving family history of cancer during the patient's initial clinic attendance, to a protocol-driven system with pre-counselling assessment of family history. The evaluation was based on retrospective clinical data and a clinical audit. Changes in risk between referral and final risk assessment were ascertained and the cost difference between the two systems estimated. The study results showed that 14{\%} of women assessed as 'low' genetic risk at referral were reassessed as 'moderate' or 'high' genetic risk for breast cancer following verification of family history. Sixteen per cent of those assessed as 'moderate' or 'high' genetic risk at referral were reassessed as 'low' genetic risk for breast cancer. Compared to the traditional system, the new protocol-driven system of risk assessment was more consistent, which reduced the number of return appointments and created time for clinicians to spend with other patients. The estimated cost of family history verification and genetic clinic appointment was calculated as 91.68 pounds (132.53 euro) per family history, compared to 104.00 pounds (150.34 euro) for the traditional system, representing a slight reduction in health service costs. Finally, the protocol-driven system can be used as part of ongoing audit for planning future genetics services in Scotland.",
keywords = "adult, aged, 80 and over, breast neoplasms, female, genetic counseling, health services needs and demand, humans, male, middle aged, retrospective studies, risk assessment, risk factors, breast cancer, cost, model of care",
author = "Helen Gregory and Sarah Wordsworth and Barbara Gibbons and Brenda Wilson and Haites, {Neva Elizabeth}",
year = "2007",
month = "11",
doi = "10.1038/sj.ejhg.5201895",
language = "English",
volume = "15",
pages = "1139--1144",
journal = "EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Risk estimation for familial breast cancer

T2 - Improving the system of counselling

AU - Gregory, Helen

AU - Wordsworth, Sarah

AU - Gibbons, Barbara

AU - Wilson, Brenda

AU - Haites, Neva Elizabeth

PY - 2007/11

Y1 - 2007/11

N2 - Women with a family history of breast cancer dominate referrals for cancer genetic risk counselling across Europe. Given limited health care resources, managing this demand, while achieving good value for money for health services, is a major challenge. The paper reports the benefits and associated costs of moving from a traditional system of deriving family history of cancer during the patient's initial clinic attendance, to a protocol-driven system with pre-counselling assessment of family history. The evaluation was based on retrospective clinical data and a clinical audit. Changes in risk between referral and final risk assessment were ascertained and the cost difference between the two systems estimated. The study results showed that 14% of women assessed as 'low' genetic risk at referral were reassessed as 'moderate' or 'high' genetic risk for breast cancer following verification of family history. Sixteen per cent of those assessed as 'moderate' or 'high' genetic risk at referral were reassessed as 'low' genetic risk for breast cancer. Compared to the traditional system, the new protocol-driven system of risk assessment was more consistent, which reduced the number of return appointments and created time for clinicians to spend with other patients. The estimated cost of family history verification and genetic clinic appointment was calculated as 91.68 pounds (132.53 euro) per family history, compared to 104.00 pounds (150.34 euro) for the traditional system, representing a slight reduction in health service costs. Finally, the protocol-driven system can be used as part of ongoing audit for planning future genetics services in Scotland.

AB - Women with a family history of breast cancer dominate referrals for cancer genetic risk counselling across Europe. Given limited health care resources, managing this demand, while achieving good value for money for health services, is a major challenge. The paper reports the benefits and associated costs of moving from a traditional system of deriving family history of cancer during the patient's initial clinic attendance, to a protocol-driven system with pre-counselling assessment of family history. The evaluation was based on retrospective clinical data and a clinical audit. Changes in risk between referral and final risk assessment were ascertained and the cost difference between the two systems estimated. The study results showed that 14% of women assessed as 'low' genetic risk at referral were reassessed as 'moderate' or 'high' genetic risk for breast cancer following verification of family history. Sixteen per cent of those assessed as 'moderate' or 'high' genetic risk at referral were reassessed as 'low' genetic risk for breast cancer. Compared to the traditional system, the new protocol-driven system of risk assessment was more consistent, which reduced the number of return appointments and created time for clinicians to spend with other patients. The estimated cost of family history verification and genetic clinic appointment was calculated as 91.68 pounds (132.53 euro) per family history, compared to 104.00 pounds (150.34 euro) for the traditional system, representing a slight reduction in health service costs. Finally, the protocol-driven system can be used as part of ongoing audit for planning future genetics services in Scotland.

KW - adult

KW - aged, 80 and over

KW - breast neoplasms

KW - female

KW - genetic counseling

KW - health services needs and demand

KW - humans

KW - male

KW - middle aged

KW - retrospective studies

KW - risk assessment

KW - risk factors

KW - breast cancer

KW - cost

KW - model of care

U2 - 10.1038/sj.ejhg.5201895

DO - 10.1038/sj.ejhg.5201895

M3 - Article

C2 - 17637807

VL - 15

SP - 1139

EP - 1144

JO - EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.

JF - EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics.

SN - 1018-4813

IS - 11

ER -